Future Microbiology

Papers
(The H4-Index of Future Microbiology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Effect of Rapamycin on Cryptococcus Neoformans : Cellular Organization, Biophysics and Virulence Factors39
Predicting of novel homoserine dehydrogenase inhibitors against Paracoccidioides brasiliensis : integrating in silico and i36
Repurposing Prokaryotic Clustered Regularly Interspaced Short Palindromic Repeats-Cas Adaptive Immune System to Combat Antimicrobial Resistance34
Propionylation of Fis K32 in Salmonella enterica serovar Typhi: a key modification affecting pathogenicity33
First Report of Rhino-Orbital-Cerebral Mucormycosis After COVID-19 Infection in Bulgaria31
No evidence for critical slowing down before measles outbreaks in the US, 2006–202530
Akkermansia muciniphila improves gastric cancer treatment by modulating the immune microenvironment23
In vitro Activities of Antibiotic Combinations Against Mature Biofilms of Ventilator-Associated Pneumonia Isolates22
Toward precision anti-biofilm therapy for Candida : a translational perspective21
Sources, transmission and hospital-associated outbreaks of nontuberculous mycobacteria: a review21
Diacetylcurcumin: a novel strategy against Enterococcus faecalis biofilm in root canal disinfection20
Hospital-Onset Bacteremia: Clinical and Regulatory Ramifications19
Design, synthesis, and characterization of guanidine derivative with broad-spectrum antimicrobial and antidiabetic inhibitory activities: a comprehensive spectroscopic and computational study18
Lactobacillus probiotics attenuate hyperlipidemia and fatty liver in rat via LPS and 5-HT-related signaling axis18
Novel automated AIMLAM for diagnosis of Mycobacterium tuberculosis17
Sulbactam–durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii16
Evaluation of the Potential Of Rejuveinix Plus Dexamethasone Against Sepsis16
A plain language summary of the LOCK IT-100 study of taurolidine/heparin catheter lock solution and catheter-related bloodstream infection in hemodialysis16
0.84641695022583